A Study for Reduction of Blood Lipid Peroxide, Interaction between Blood-Carotenoids and Effect on Cognitive Impairment by Ingestion of Chlorella-containing Food - A Study for Reduction of Blood Lipid Peroxide, Interaction between Blood-Carotenoids and Effect on Cognitive Impairment by Ingestion of Chlorella-containing Food

TES Holdings Co., Ltd.0 个研究点目标入组 60 人开始时间: 2014年4月18日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Individuals judged inappropriate for the study by the principal investigator 2) Individuals who routinely take proprietary drugs and health foods including beverages (chlorella foods, carotenoids and other products professing to improve lipid absorption and metabolic function) 3) Individuals who take lipid metabolism improver (e.g. ethyl icosapentate, statin, fibrate, anion exchange resin and ezetimibe) 4) Individuals who take warfarin 5) Individuals who take anti-dementia drugs, antidepressant drugs, antipsychotic drugs and anti-anxiety drugs 6) Individuals who excessively take alcohol and tobacco 7) Individuals who are sensitive to medical products and cosmetics 8) Individuals who participated in other clinical studies 9) Individuals who have anamnesis or history of present illness of head injury, cerebral stroke and epilepsia 10) Individuals who have serious hepatopathy, kidney damage and heart disease 11) Individuals whose observed data of GT is over 300mg/dL 12) Individuals whose observed data of gamma-GTP is over 2 times of upper value (male: 75 U/L, female: 45 U/L) 13) Individuals whose observed data of AST is over 2 times of upper value (male and female: 40 U/L) 14) Individuals whose observed data of ALT is over 2 times of upper value (male and female: 45 U/L) 15) Individuals whose observed data of SCR is over 2.0mg/d

发起方